Canagliflozin Reduces the Risk of Kidney Failure in Patients with Type 2 Diabetes Mellitus and Nephropathy: The CREDENCE Randomized Trial
Crossref DOI link: https://doi.org/10.1007/s11606-020-06216-z
Published Online: 2021-02-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Halalau, Alexandra http://orcid.org/0000-0002-1805-992X
Fuller, William
Wheeler, Stephanie
Text and Data Mining valid from 2021-02-05
Version of Record valid from 2021-02-05
Article History
Received: 10 May 2020
Accepted: 3 September 2020
First Online: 5 February 2021
Compliance with Ethical Standards
: The authors have no conflict of interest to disclose.
Free to read: This content has been made available to all.